I. Edelson
Direktor/Vorstandsmitglied bei DISTRIBUTION SOLUTIONS GROUP, INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bryan King | M | 53 | 7 Jahre | |
| Ronald Knutson | M | 60 | 15 Jahre | |
| Simon Benita | M | - |
Bionanosim (BNS) Ltd.
 Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | - |
| Richard Pufpaf | M | - | 13 Jahre | |
| Lee Hillman | M | 69 | 20 Jahre | |
| Michael Reinsdorf | M | - |
Mercantile Capital Markets LLC
 Mercantile Capital Markets LLC Investment ManagersFinance Mercantile Capital Markets LLC is a private equity firm founded in 1997. It is headquartered in Wilmette, Illinois.
International Facilities Group LLC
 International Facilities Group LLC Miscellaneous Commercial ServicesCommercial Services International Facilities Group LLC engages in the provision of project management services. It offers site analysis, design administration, construction oversight, equipment procurement, facility commissioning, and asset management. The company was founded by I Steven Edelson in 1995 and is headquartered in Chicago, IL. | - |
| Yosi Ben-Dov | M | - |
The Hebrew University of Jerusalem
| 10 Jahre |
| Mark Moon | M | 61 | 5 Jahre | |
| Robert Zamarripa | M | 68 | 2 Jahre | |
| Bilha Shapira | F | 71 |
The Hebrew University of Jerusalem
| 15 Jahre |
| Hermona Soreq | M | - |
The Hebrew University of Jerusalem
| - |
| Bianca Rhodes | F | 65 | 3 Jahre | |
| Jacob Avraham Neuman | M | 75 |
The Hebrew University of Jerusalem
| 42 Jahre |
| Miriyam Katz | F | 73 |
The Hebrew University of Jerusalem
| 9 Jahre |
| Tamar Yassur | F | 58 |
The Hebrew University of Jerusalem
| - |
| Abraham Israeli | M | 70 |
The Hebrew University of Jerusalem
| 28 Jahre |
| David Kolitz | M | 81 |
The Hebrew University of Jerusalem
| - |
| Marta Weinstock-Rosin | F | - |
The Hebrew University of Jerusalem
| - |
| Alon Moran | M | - |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | - |
| Naomi Chazan | F | - |
The Hebrew University of Jerusalem
| - |
| Itzhak Galnoor | M | - |
The Hebrew University of Jerusalem
| - |
| Sarah Ozacky-Lazar | M | - |
The Hebrew University of Jerusalem
| 19 Jahre |
| Keren-Or Amar | M | - |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | 4 Jahre |
| Billy Shapira | F | - |
The Hebrew University of Jerusalem
| - |
| Isaiah Arkin | M | - |
The Hebrew University of Jerusalem
| 15 Jahre |
| Saul Yedgar | M | 82 |
The Hebrew University of Jerusalem
| 42 Jahre |
| Zvi Ioav Cabantchik | M | - |
The Hebrew University of Jerusalem
| 45 Jahre |
| Anwar Mahmoud Rayan | M | - |
The Hebrew University of Jerusalem
| - |
| Zvi Wiener | M | - |
The Hebrew University of Jerusalem
| - |
| Udi Nissan Nisan | M | 55 |
The Hebrew University of Jerusalem
| - |
| Maya Liquornik | F | 68 |
The Hebrew University of Jerusalem
| - |
| Itamar Borowitz | M | 80 |
The Hebrew University of Jerusalem
| - |
| Shimon Shitrit | M | 78 |
The Hebrew University of Jerusalem
| 28 Jahre |
| Yaron Ilan | M | 64 |
The Hebrew University of Jerusalem
| 26 Jahre |
| David Lambert | M | - | 3 Jahre | |
| Matthew J. Brown | M | 60 | 23 Jahre | |
| Adi Ben-Nun | M | - |
The Hebrew University of Jerusalem
| 30 Jahre |
| Nechama Tzivin | F | 70 |
The Hebrew University of Jerusalem
| - |
| Matt Boyce | M | - | 2 Jahre | |
| Amotz Agnon | M | 69 |
The Hebrew University of Jerusalem
| - |
| Ilan Kremer | M | 57 |
The Hebrew University of Jerusalem
| 13 Jahre |
| Menachem Magidor | M | - |
The Hebrew University of Jerusalem
| - |
| Mark Appell | M | - |
International Facilities Group LLC
International Facilities Group LLC Miscellaneous Commercial ServicesCommercial Services International Facilities Group LLC engages in the provision of project management services. It offers site analysis, design administration, construction oversight, equipment procurement, facility commissioning, and asset management. The company was founded by I Steven Edelson in 1995 and is headquartered in Chicago, IL. | - |
| Uzi Vardi Zer | M | 85 |
The Hebrew University of Jerusalem
| - |
| Moshe Vidman | M | 80 |
The Hebrew University of Jerusalem
| 29 Jahre |
| Raphael Gorodetsky | M | - |
The Hebrew University of Jerusalem
| - |
| Yair Seroussi | M | 68 |
The Hebrew University of Jerusalem
| - |
| Isaac Manor | M | 83 |
The Hebrew University of Jerusalem
| - |
| Bradley Wallace | M | 51 | 1 Jahre | |
| Ron Hadassi | M | 59 |
The Hebrew University of Jerusalem
| - |
| Leon Recanati | M | 76 |
The Hebrew University of Jerusalem
| - |
| Gurion Meltzer | M | - |
The Hebrew University of Jerusalem
| - |
| David Avnir | M | - |
The Hebrew University of Jerusalem
| - |
| Yehoshua Gleitman | M | 74 |
The Hebrew University of Jerusalem
| 5 Jahre |
| Harel Beit On | M | 64 |
The Hebrew University of Jerusalem
| 6 Jahre |
| Amnon Shashua | M | 63 |
The Hebrew University of Jerusalem
| 22 Jahre |
| Erel Margalit | M | 63 |
The Hebrew University of Jerusalem
| - |
| Richard Ziman | M | 81 |
The Hebrew University of Jerusalem
| - |
| Giora Yaron | M | 75 |
The Hebrew University of Jerusalem
| - |
| Martin S. Gerstel | M | 83 |
The Hebrew University of Jerusalem
| - |
| Ari Kellen | M | - |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | 6 Jahre |
| Jonathan Brodie | M | 67 |
The Hebrew University of Jerusalem
| - |
| Dan Suesskind | M | 80 |
The Hebrew University of Jerusalem
| - |
| Shmuel A. Ben-Sasson | M | - |
The Hebrew University of Jerusalem
| - |
| Michael Schieber | M | - |
The Hebrew University of Jerusalem
| - |
| Taher Nassar | M | - |
The Hebrew University of Jerusalem
| - |
| Jacob George | M | 59 |
The Hebrew University of Jerusalem
| - |
| Gordon Brian Stephen Hausmann | M | 78 |
The Hebrew University of Jerusalem
| - |
| Doron Shorrer | M | 41 |
The Hebrew University of Jerusalem
| - |
| Arie Altman | M | - |
The Hebrew University of Jerusalem
| - |
| Aharon M. Eyal | M | - |
The Hebrew University of Jerusalem
| - |
| Avraham Baniel | M | - |
The Hebrew University of Jerusalem
| - |
| Geila Rozen | M | - |
The Hebrew University of Jerusalem
| - |
| Samuel Blumenfeld | M | 86 |
The Hebrew University of Jerusalem
| - |
| Alexander Levitzki | M | - |
The Hebrew University of Jerusalem
| 47 Jahre |
| Yoav Aharoni | M | - |
The Hebrew University of Jerusalem
| - |
| Eyal Mishani | M | - |
The Hebrew University of Jerusalem
| - |
| Andrew L. Shapiro | M | 56 |
The Hebrew University of Jerusalem
| - |
| Lawrence E. Glick | M | - |
The Hebrew University of Jerusalem
| - |
| Hanoch Rappaport | M | - |
The Hebrew University of Jerusalem
| - |
| Suhail Ayesh | M | - |
The Hebrew University of Jerusalem
| - |
| Patricia Ohana | M | - |
The Hebrew University of Jerusalem
| - |
| David Gershon | M | 59 |
The Hebrew University of Jerusalem
| 7 Jahre |
| Oded Shoseyov | M | 67 |
The Hebrew University of Jerusalem
| 34 Jahre |
| Joelle Aflalo | F | - |
Bionanosim (BNS) Ltd.
Bionanosim (BNS) Ltd. Pharmaceuticals: MajorHealth Technology Bionanosim (BNS) Ltd. is an Israeli company that specializes in the manufacturing of independent nanocarrier-based drugs for clinical testing. The company is based in Jerusalem, Israel. Rafarm is based in Greece. The company is led by Prof. Simon Benita, who has decades of scientific expertise and proven commercial success in bringing nanoparticle-based products to market. Bionanosim is affiliated with the Hebrew University and has a talented cross-functional team that enables them to target multiple areas of unmet needs simultaneously. Rafarm, on the other hand, is an innovation-driven pharmaceutical company that invests 13%% of net turnover in research and development. The company is a well-established European manufacturer that constantly enhances their expertise in complex pharmaceutical products and invests in high-tech platforms for the development and production of ophthalmics and injectables. The company was founded by Joseph C. Papa and Simon Benita, with Simon Benita serving as the CEO since incorporation. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Neil E. Jenkins | M | 74 | 20 Jahre | |
| Thomas J. Neri | M | 72 | 9 Jahre | |
| Michael Tuvell | M | - | 6 Jahre | |
| Michael DeCata | M | 66 | 10 Jahre | |
| Shane McCarthy | M | - | 14 Jahre | |
| Wilma J. Smelcer | F | 75 | 15 Jahre | |
| Ronald B. Port | M | 82 | 35 Jahre | |
| Nathaniel C. A. Kramer | M | 62 |
Mercantile Capital Group LLC
 Mercantile Capital Group LLC Financial ConglomeratesFinance Part of Mercantile Capital Management Corp., Mercantile Capital Group LLC provides asset management services. The company is based in New York, NY.
Mercantile Capital Markets LLC
Mercantile Capital Markets LLC Investment ManagersFinance Mercantile Capital Markets LLC is a private equity firm founded in 1997. It is headquartered in Wilmette, Illinois. | 13 Jahre |
| Tom Postek | M | 82 | 14 Jahre | |
| William Holmes | M | 60 | 22 Jahre | |
| Charles Hale | M | 58 | - | |
| Stewart A. Howley | M | 62 | 7 Jahre | |
| Andrew Albert | M | 78 | 15 Jahre | |
| James S. Errant | M | 75 | 12 Jahre | |
| Harry A. Dochelli | M | 64 | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Israel | 72 | 72,00% |
| Vereinigte Staaten | 28 | 28,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- I. Edelson
- Persönliches Netzwerk